Once-Weekly Insulin Icodec vs. Once-Daily Insulin Glargine U100 for type 2 diabetes: a systematic review and meta-analysis of phase 2 randomized controlled trials

OBJECTIVE: Insulin Icodec is a novel basal insulin analogue designed for once-weekly administration, therefore might propitiate reduction in the frequency of injections and facilitate treatment adherence. This study aimed to determine the glycemic control and safety profile of Insulin Icodec, compar...

Descripción completa

Detalles Bibliográficos
Autores principales: Silva, Rodrigo Ribeiro e, Gauza, Mateus de Miranda, Guisso, Maria Eduarda Schramm, da Silva, Júlia Opolski Nunes, Kohara, Suely Keiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Endocrinologia e Metabologia 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665058/
https://www.ncbi.nlm.nih.gov/pubmed/37249450
http://dx.doi.org/10.20945/2359-3997000000614

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665058/
https://www.ncbi.nlm.nih.gov/pubmed/37249450
http://dx.doi.org/10.20945/2359-3997000000614

Ejemplares similares